KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Debt (2016 - 2025)

Historic Total Debt for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $66.8 billion.

  • AbbVie's Total Debt fell 607.49% to $66.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $66.8 billion, marking a year-over-year decrease of 607.49%. This contributed to the annual value of $67.1 billion for FY2024, which is 1306.56% up from last year.
  • As of Q3 2025, AbbVie's Total Debt stood at $66.8 billion, which was down 607.49% from $65.0 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Total Debt ranged from a high of $85.5 billion in Q1 2021 and a low of $59.4 billion during Q4 2023
  • For the 5-year period, AbbVie's Total Debt averaged around $70.0 billion, with its median value being $69.6 billion (2022).
  • In the last 5 years, AbbVie's Total Debt surged by 2756.71% in 2021 and then tumbled by 1747.75% in 2022.
  • Over the past 5 years, AbbVie's Total Debt (Quarter) stood at $76.7 billion in 2021, then fell by 17.48% to $63.3 billion in 2022, then decreased by 6.14% to $59.4 billion in 2023, then increased by 13.07% to $67.1 billion in 2024, then dropped by 0.57% to $66.8 billion in 2025.
  • Its Total Debt stands at $66.8 billion for Q3 2025, versus $65.0 billion for Q2 2025 and $68.3 billion for Q1 2025.